These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16843175)

  • 1. The prognostic importance of nonsignificant left main coronary artery disease in patients undergoing percutaneous coronary intervention.
    Gyenes G; Shrive FM; Graham MM; Ghali WA; Knudtson ML;
    J Am Coll Cardiol; 2006 Jul; 48(2):276-80. PubMed ID: 16843175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features.
    Brener SJ; Lytle BW; Casserly IP; Schneider JP; Topol EJ; Lauer MS
    Circulation; 2004 May; 109(19):2290-5. PubMed ID: 15117846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era.
    Kimura T; Morimoto T; Furukawa Y; Nakagawa Y; Shizuta S; Ehara N; Taniguchi R; Doi T; Nishiyama K; Ozasa N; Saito N; Hoshino K; Mitsuoka H; Abe M; Toma M; Tamura T; Haruna Y; Imai Y; Teramukai S; Fukushima M; Kita T
    Circulation; 2008 Sep; 118(14 Suppl):S199-209. PubMed ID: 18824755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report.
    Brener SJ; Milford-Beland S; Roe MT; Bhatt DL; Weintraub WS; Brindis RG;
    Am Heart J; 2008 Jan; 155(1):140-6. PubMed ID: 18082505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease.
    Dacey LJ; Likosky DS; Ryan TJ; Robb JF; Quinn RD; DeVries JT; Hearne MJ; Leavitt BJ; Dunton RF; Clough RA; Sisto D; Ross CS; Olmstead EM; O'Connor GT; Malenka DJ;
    Ann Thorac Surg; 2007 Dec; 84(6):1904-11; discussion 1904-11. PubMed ID: 18036905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
    Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
    Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: a cross-sectional study.
    Alidoosti M; Salarifar M; Zeinali AM; Kassaian SE; Dehkordi MR
    BMC Cardiovasc Disord; 2007 Mar; 7():7. PubMed ID: 17335586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
    Tamburino C; Di Salvo ME; Capodanno D; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S
    Am J Cardiol; 2009 Jan; 103(2):187-93. PubMed ID: 19121434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients.
    Brener SJ; Galla JM; Bryant R; Sabik JF; Ellis SG
    Am J Cardiol; 2008 Jan; 101(2):169-72. PubMed ID: 18178401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of noncoronary vascular disease in predicting adverse events in the year following percutaneous coronary intervention.
    Naidu SS; Vlachos H; Faxon D; Jacobs AK; Selzer F; Detre K; Wilensky RL
    Am J Cardiol; 2005 Mar; 95(5):575-80. PubMed ID: 15721094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C; Angiolillo DJ; Capranzano P; Dimopoulos K; La Manna A; Barbagallo R; Tagliareni F; Mangiafico S; Guzman LA; Galassi AR; Bass TA
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):448-56. PubMed ID: 18814218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
    Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A
    Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.